Introduction In Singapore, the rapid growth of the digital economy has brought about a pressing need to balance technological advancement
In recent years, biologics have emerged as one of the most promising frontiers in medicine. From monoclonal antibodies to engineered
Biotechnology is witnessing a surge of innovation in phage discovery, with new functional screening platforms reshaping drug development and antibody
Microfluidics—a field that deals with the manipulation of fluids at the microscale—is quietly revolutionizing how we study biology, develop drugs,
Traditional drug screening and disease modeling—long reliant on 2D cell cultures and animal models—are increasingly criticized for their limited predictive
In the world of drug formulation research and nanotechnology, lipid-based delivery systems have captured the attention of scientists aiming to
In the shadow of every viral outbreak lies a deeper challenge: how do we deliver therapeutics precisely, safely, and effectively
Anti-glycan antibodies represent one of the most promising yet challenging frontiers in biotechnology. Their ability to decode the “sugar language”
“Glycosylation is not decoration—it’s communication,” notes a recent review in Nature Reviews Drug Discovery (Vol. 21, 2022). That simple statement captures
Base editing stands at the forefront of genomic engineering, representing a paradigm shift in how scientists can modify DNA with
